NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/10/2024
Back to search
Official data from USPTO
ASA PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ASA PHARMACEUTICAL
ST13
US500000097904692Class
5
Filing
97904692
Registration
7498699
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
04/24/2023
Registration date
09/10/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/10/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
29
Owner location
Tokyo, JP
Examiner
STADELI, MARTA ANN
Law office
N50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Asa Pharmaceutical Co., Ltd.
Representatives
Yukihiro Takemoto SMARCA IP P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vitamin preparations; cod-liver oil drops; Mixed vitamin preparations; vitamin A preparations; vitamin C preparations; vitamin D preparations; vitamin B preparations; multi-vitamin preparations; amino acid preparations for medical purposes; nutrients and tonicsnutritional supplements containing Nicotinamide Mononucleotide (NMN); dietary supplements; granular processed foods containing chlorella as a main ingredientchlorella for use as a dietary food supplement; granular processed foods containing yeast as a main ingredientbrewer's yeast as a dietary food supplement; dietary supplements containing propolis as a main ingredient; dietary supplements containing acai powder as a main ingredient; dietary supplements containing flaxseed as a main ingredient; dietary supplements containing linseed as a main ingredient; dietary supplements containing alginate as a main ingredient; dietary supplements containing albumin as a main ingredient; nutritional supplements; dietary supplements containing casein as a main ingredient; dietary supplements containing pollen as a main ingredient; dietary supplements containing glucose as a main ingredient; dietary supplements containing enzyme as a main ingredient; dietary supplements containing yeast as a main ingredient; dietary supplements containing wheat germ as a main ingredient; vitamin supplement patches; dietary supplements with a cosmetic effect; dietary supplements containing protein as a main ingredient; dietary supplements containing mineral as a main ingredientmineral dietary supplements; dietary supplements containing lecithin as a main ingredient; dietary supplements containing royal jelly as a main ingredient
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/10/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/25/2024
PUBO
PUBLISHED FOR OPPOSITION
06/25/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/20/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/20/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/20/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/22/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/25/2024
GNRT
NON-FINAL ACTION E-MAILED
01/25/2024
CNRT
NON-FINAL ACTION WRITTEN
01/25/2024
DOCK
ASSIGNED TO EXAMINER
01/19/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/22/2023
NWAP
NEW APPLICATION ENTERED
04/27/2023
Continuous trademark protection
Get notified about every new filing that threatens ASA PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.